Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2, Issue 2, Pages 209-215
http://dx.doi.org/10.1093/ecam/neh081
Original Article

Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3)

1Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei, Taiwan
2Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan
3Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan

Received 30 September 2004; Accepted 11 March 2005

Copyright © 2005 Chia-Nan Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Chia-Nan Chen, Coney P. C. Lin, Kuo-Kuei Huang, et al., “Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3),” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 2, pp. 209-215, 2005. https://doi.org/10.1093/ecam/neh081.